Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.

Types of peer-reviewed articles published:

-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:

1.Factors influencing human sensitivity

2.Exposure science related to risk assessment

3.Alternative toxicological test methods

4.Frameworks for evaluation and integration of data in regulatory evaluations

5.Harmonization across regulatory agencies

6.Read-across methods and evaluations

-Contemporary Reviews on policy related Research issues

-Letters to the Editor

-Guest Editorials (by Invitation)

《Regulatory Toxicology And Pharmacology》是一本由ACADEMIC PRESS INC ELSEVIER SCIENCE出版商出版的专业医学期刊，该刊创刊于1981年，刊期Monthly，该刊已被国际权威数据库SCI、SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：医学：法 3区；药学 3区；毒理学 3区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖医学：法等领域，旨在及时、准确、全面地报道国内外医学：法工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为3.598，平均审稿速度平均3月。